Olema Pharmaceuticals, Inc. SEC filings OLMA
Olema Pharmaceuticals, Inc. has 562 filings in SEC EDGAR's recent list, going back to Aug 27, 2018. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 15, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 15, 2026 | Oct 12, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2026 | Aug 10, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2026 | Jun 17, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 26, 2026 | May 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 21, 2026 | May 21, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Material agreement, New debt
|
May 1, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 29, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 30, 2026 | Jan 27, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 8-K |
Current report
Other events
|
Nov 19, 2025 | Nov 19, 2025 |
| 8-K |
Current report
Other events
|
Nov 18, 2025 | Nov 18, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 20, 2025 | Oct 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 2, 2025 | Sep 2, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 11, 2025 | Aug 11, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2025 | Jun 10, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 5, 2025 | Mar 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Unregistered share sale
|
Jan 10, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 10, 2024 | Dec 9, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Dec 2, 2024 | Nov 29, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 27, 2024 | Sep 27, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 2, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 13, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 15, 2024 | May 15, 2024 |
| 8-K |
Current report
Results of operations
|
May 8, 2024 | May 8, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2024 | Mar 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 8, 2024 | Jan 8, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 5, 2024 | Jan 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 6, 2023 | Dec 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 5, 2023 | Dec 5, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 23, 2023 | Oct 22, 2023 |
| 8-K/A |
Amended current report
Officer or director change, Regulation FD disclosure
|
Oct 18, 2023 | Oct 13, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 17, 2023 | Oct 13, 2023 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 10, 2023 | Oct 9, 2023 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale
|
Sep 5, 2023 | Sep 5, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2023 | Aug 8, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Other events
|
May 11, 2023 | May 11, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 9, 2023 | Mar 9, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 16, 2022 | Dec 15, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Material agreement
|
Jun 9, 2022 | Jun 7, 2022 |
| 8-K |
Current report
Results of operations
|
May 9, 2022 | May 9, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 14, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2022 | Feb 28, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2021 | Aug 10, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2021 | Jun 8, 2021 |
| 8-K |
Current report
Results of operations
|
May 11, 2021 | May 11, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 6, 2021 | Apr 5, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2021 | Mar 17, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Nov 23, 2020 | Nov 23, 2020 |
Showing 66 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OLMA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1750284
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.